Business Alignment PCL (BKK:BIZ) EBIT: ฿506 Mil (TTM As of Mar. 2026)


BKK:BIZ Business Alignment PCL BKK:BIZ
86 GF Score
Price ฿5.95
GF Value ฿5.36
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Business Alignment PCL EBIT?

Business Alignment PCL BKK:BIZ -0.83% 86 EBIT is ฿506 Mil as of Mar. 2026. GuruFocus rates BKK:BIZ with a GF Score™ of 86/100 and a GF Value™ of ฿5.36 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Business Alignment PCL's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ฿132 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ฿506 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Business Alignment PCL's annualized ROC % for the quarter that ended in Mar. 2026 was 32.06%. Business Alignment PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 62.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Business Alignment PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 15.81%.


Business Alignment PCL  (BKK:BIZ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Business Alignment PCL's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=502.46 * ( 1 - 20.13% )/( (1633.58 + 869.586)/ 2 )
=401.314802/1251.583
=32.06 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1978.535 - 178.468 - ( 166.487 - max(0, 684.685 - 1456.807+166.487))
=1633.58

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2046.146 - 478.59 - ( 697.97 - max(0, 670.861 - 1529.115+697.97))
=869.586

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Business Alignment PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=528.108/( ( (319.363 + max(773.819, 0)) + (314.755 + max(277.924, 0)) )/ 2 )
=528.108/( ( 1093.182 + 592.679 )/ 2 )
=528.108/842.9305
=62.65 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(542.508 + 542.056 + 107.274) - (178.468 + 220.858 + 18.693)
=773.819

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(197.242 + 447.339 + 129.32) - (478.59 + 0 + 17.387)
=277.924

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Business Alignment PCL's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=506.095/3201.750
=15.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Business Alignment PCL EBIT Related Terms


Business Alignment PCL EBIT Historical Data

* Premium members only.

The historical data trend for Business Alignment PCL's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Business Alignment PCL EBIT Chart

Business Alignment PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 550.51 181.06 258.53 287.58 391.01

Business Alignment PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.94 59.59 247.22 67.26 132.03

BKK:BIZ vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Business Alignment PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Business Alignment PCL EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Business Alignment PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Business Alignment PCL's EV-to-EBIT falls into.


BKK:BIZ
86GF Score
Business Alignment PCL BKK:BIZ
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Business Alignment PCL EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿506 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ฿506 Mil mean?
Business Alignment PCL (BKK:BIZ) has a EBIT of ฿506 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Business Alignment PCL.
Is Business Alignment PCL's EBIT too high?
Business Alignment PCL's current EBIT is ฿506 Mil. Overall, Business Alignment PCL has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Business Alignment PCL's EBIT compare to ABT and SYK?
Business Alignment PCL's EBIT of ฿506 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Business Alignment PCL. Business Alignment PCL's current EBIT is ฿506 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Business Alignment PCL stock overvalued right now?
Based on GuruFocus' analysis, Business Alignment PCL (BKK:BIZ) is currently considered Modestly Overvalued. The stock's GF Value™ is ฿5.36, compared to a current price of ฿5.95 — trading 11% above its estimated fair value. The current EBIT is ฿506 Mil. Business Alignment PCL's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Business Alignment PCL (BKK:BIZ), the current EBIT is ฿506 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Business Alignment PCL (BKK:BIZ) Overvalued in 2026?

Based on GuruFocus' analysis, Business Alignment PCL stock appears to be overvalued. The current stock price of ฿5.95 is trading 11% above its estimated GF Value™ of ฿5.36. GuruFocus considers Business Alignment PCL to be Modestly Overvalued.

Key valuation signals for BKK:BIZ:

  • EBIT: ฿506 Mil
  • GF Value™: ฿5.36 vs. price of ฿5.95 (11% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the BKK:BIZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Business Alignment PCL Business Description

Address North Sathorn Road, 92/45 Sathorn Thani Building 2, 16th Floor, Silom Sub-District, Bangrak District, Bangkok, THA, 10500
Business Alignment PCL is engaged in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company operates through the sale of medical equipment segment which includes installation, repair, and maintenance. In addition, it also focuses on increasing the efficiency of medical equipment; and Hospital operations (specialized in cancer treatment). The company is a distributor for Radiotherapy products and Brachytheraphy products in Thailand and Cambodia. Geographically, it operates in the region of Thailand.
86GF Score

Get the complete analysis for BKK:BIZ

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.95
Price
฿5.36
GF Value